TABLE 5.
Pharmacological treatment for VaD and their effects.
Drug classes | Drugs | Effects |
Cholinesterase inhibitors | Donepezil, Galantamine, Rivastigmine | Safe and effective in reducing the progression of VaD in addressing the behavioral problems. |
Vasodilators | Niacin (nicotinic acid), Cyclandelate, Papaverine, Isoxsuprine, Cinnarizine, Buflomedil, Naftidrofuryl, Ergoloid mesylates, Acetazolamide | Have shown to be less effective in treating VaD compared to cortical dementias like Alzheimer’s. |
Calcium channel blockers | Nimodipine | Moderately effective for short term in treating cerebrovascular disease and other types of dementia. |
N-methyl-D-aspartate (NMDA) antagonists | Nicardipine | Improvement of cognitive deterioration |
NMDA antagonists | Memantine | Improve cognition consistently across different cognitive scales, with at least no deterioration in global functioning and behavior. |
Nootropic agents | Piracetam, Nicergoline, Oxiracetam Citicoline, Pentoxifylline | have beneficial effects for patients with dementia in prolonging their survival. |
Antiplatelet agents | Aspirin, Triflusal, Ginkgo biloba | Reduce/prevent the occurrence of stroke. |